Harmeet Kaur

Harmeet Kaur

Active Director Director DIN 01737331
DIN 01737331 First appointment Aug 2007 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Aug 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Harmeet Kaur

Data last updated:

Harmeet Kaur is a Director at Iberia Pharmaceuticals India Limited (since 2025) and Partner at Rrr Insolvency Service Experts Llp (since 2025). The companies operate in Trading, Travel and Hospitality and Financial Services. The largest current company by reported revenue is Iberia Pharmaceuticals India Limited at ₹67.39 Cr (FY 2023). Earlier, Harmeet Kaur was a Director at Larisa Hotels & Resorts Limited (2025) and Director at Dholadhar Investments Private Limited (2007–2012) and 2 more.

DIN 01737331
Primary Designation Director
Industry Trading
First Appointment 04 Aug 2007
Oldest Company Age 13 yrs
Largest company Iberia Pharmaceuticals India Limited Β· ₹67.39 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Iberia Pharmaceuticals India Limited U24232DL2013PLC250040
Director01 Mar 20252013₹67.39 Cr (FY 2023)Active
Partner23 Jan 20252020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Larisa Hotels & Resorts Limited U55100WB1986PLC040325
Director18 Jan 20251986₹25.81 Cr (FY 2025)Active
Director04 Aug 20071992₹1.89 Cr (FY 2025)Active
Uniworld Sugars Private Limited U15422UP2009PTC038540
Company Secretary15 Mar 20122009₹14.5 Lakh (FY 2022)Amalgamated
Director01 May 20141995₹3.7 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rrr Insolvency Service Experts Llp
Iberia Pharmaceuticals India Limited
Larisa Hotels & Resorts Limited
Dholadhar Investments Private Limited
Premium access

Shareholding and investment profile for Harmeet Kaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harmeet Kaur

Harmeet Kaur currently holds 2 directorships: Iberia Pharmaceuticals India Limited (Director, since 01 Mar 2025, revenue β‚Ή67.39 Cr (FY 2023)); Rrr Insolvency Service Experts Llp (Partner, since 23 Jan 2025).

Harmeet Kaur was first appointed on 04 Aug 2007 as Director at Dholadhar Investments Private Limited. The most recent appointment on record is 01 Mar 2025 at Iberia Pharmaceuticals India Limited.

Harmeet Kaur held 4 earlier board appointments: Larisa Hotels & Resorts Limited (Director, 18 Jan 2025 to 24 Nov 2025); Dholadhar Investments Private Limited (Director, 04 Aug 2007 to 11 Jul 2012); Uniworld Sugars Private Limited (Company Secretary, 15 Mar 2012 to 26 Dec 2017); Simbhaoli Speciality Sugars Private Limited (Director, 01 May 2014 to 27 Dec 2020).

The current boards of Harmeet Kaur's companies include Aditya Rungta (Iberia Pharmaceuticals India Limited), Atul Bhola (Iberia Pharmaceuticals India Limited), Deepanshu (Iberia Pharmaceuticals India Limited), Nitin Jain (Iberia Pharmaceuticals India Limited), Rishab Jain (Iberia Pharmaceuticals India Limited), Saurav Ojha (Iberia Pharmaceuticals India Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available